Cargando...
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with advanced BRAFV600 mutated melanoma has shown objective tumor responses in approximately half of the patients. However, the duration of responses is limited in a majority of these patients, with progression-free surviva...
Guardado en:
| Publicado en: | Ther Adv Med Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699264/ https://ncbi.nlm.nih.gov/pubmed/26753005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015616934 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|